Mechanistic Insights into FOLFOX-Induced Neurotoxicity and Determination of Its Concentrations via a Novel, Simultaneous HPLC Quantification Method in Brain Tissue
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s539603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Rasha A Mansouri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Faculty of Science and Humanities, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Fluorouracil, Brain, Antineoplastic Combined Chemotherapy Protocols, Neurotoxicity Syndromes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
FOLFOX, a commonly prescribed chemotherapeutic regimen, associated with significant neurotoxicity, that necessitates stop administration in some cases, hence, this study aimed to investigate the molecular mechanisms underlying FOLFOX-induced neurotoxicity in the brain and sciatic nerve, and determining its cerebral concentration via HPLC technique.
Methods
48 rats were divided into four groups: normal control, Oxaliplatin (6 mg/kg), 5-Fluorouracil (50 mg/kg), and a combination group (oxaliplatin 6 mg/kg + 5-fluorouracil 50 mg/kg). Behavioral tests in addition to samples collection from cerebral tissues, sciatic nerves, and blood were conducted. Tissue histological and biochemical changes were determined, including oxidative stress markers (Nrf2, SOD2, HO-1), apoptotic proteins (Bax, cCaspase-3, Bcl-2), and inflammatory biomarkers (COX-II, TNF-α, IL-6, NF-κβ). A new HPLC method was developed and validated to quantify oxaliplatin and 5-fluorouracil (5-Flu) concentrations in the brain tissue.
Results
Both oxaliplatin and 5-Flu induced a substantial oxidative stress, evidenced by reduced expression of Nrf2, SOD2, and HO-1 proteins, associated with a significant upregulation of the pro-apoptotic proteins Bax and cleaved caspase-3, and downregulation of the anti-apoptotic protein Bcl-2. Inflammatory markers were increased in all treated groups, and the highest levels were observed in the combination group. HPLC analysis confirmed a significantly higher concentration of both drugs in the cerebral tissue of the combination group. Histopathological findings revealed neuronal damage and inflammation associated by increased Glial fibrillary acidic protein (GFAP) and decreased neural cell adhesion molecule (NCAM) expression. Behavioral assessments demonstrated markedly reduced pain thresholds in treated animals.
Conclusion
This study identified a novel mechanisms underlying FOLFOX neurotoxicity involving activation of the pro-apoptotic BAX/cCaspase-3 pathway and suppression of the Nrf2/KEAP-1/SOD2/HO-1 antioxidant defense mechanism. These disorders induced a neuronal injury, evidenced by altered GFAP and NCAM expression. The findings highlight the synergistic role of FOLFOX components in driving oxidative stress, apoptosis, and inflammation, collectively contributing to neurotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Faculty of Science and Humanities, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena, Egypt.
- Embryonic Stem Cell Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Sadat City, Sadat, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, South Valley University, Qena, Egypt.
ORCID-Profile: Adel M Ahmed, Esam M Aboubakr
Zitieren
APA
Mansouri, R. A., Ahmed, A. M., Alshaibi, H. F., Fouda, W. M., & Aboubakr, E. M. (2025). Mechanistic Insights into FOLFOX-Induced Neurotoxicity and Determination of Its Concentrations via a Novel, Simultaneous HPLC Quantification Method in Brain Tissue. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s539603
Vancouver
Mansouri RA, Ahmed AM, Alshaibi HF, Fouda WM, Aboubakr EM. Mechanistic Insights into FOLFOX-Induced Neurotoxicity and Determination of Its Concentrations via a Novel, Simultaneous HPLC Quantification Method in Brain Tissue. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s539603
BibTeX
@article{Mansouri2025,
author = {Mansouri, Rasha A and Ahmed, Adel M and Alshaibi, Huda F and Fouda, Wafaa M and Aboubakr, Esam M},
title = {Mechanistic Insights into FOLFOX-Induced Neurotoxicity and Determination of Its Concentrations via a Novel, Simultaneous HPLC Quantification Method in Brain Tissue},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s539603}
}
EUVIMED